Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7485268rdf:typepubmed:Citationlld:pubmed
pubmed-article:7485268lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0700287lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0001655lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0008660lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0005586lld:lifeskim
pubmed-article:7485268lifeskim:mentionsumls-concept:C0024779lld:lifeskim
pubmed-article:7485268pubmed:issue4lld:pubmed
pubmed-article:7485268pubmed:dateCreated1995-12-15lld:pubmed
pubmed-article:7485268pubmed:abstractTextWe have examined the possible linkage of adrenocorticotropin receptor/melanocortin receptor-2 (ACTHR/MC-2) to a reported putative susceptibility locus for bipolar illness (BP) in 20 affected pedigrees. Initially, allelic variants of the gene were identified by polymerase chain reaction-single stranded conformation polymorphism (PCR-SSCP) and the gene was genetically mapped using both the Centre d'Etudes du Polymorphisme Humain (CEPH) pedigrees and the BP pedigrees used in this study. We found that the ACTHR/MC-2 gene maps between D18S53 and D18S66. These loci span a region of chromosome 18 which, in a previous study [Berrettini et al.: Proc Natl Acad Sci USA 91:5918-5921, 1994) revealed a putative predisposing locus to BP through nonparametric methods of linkage analysis. Linkage of ACTHR/MC-2 to BP was not demonstrable under parametric and nonparametric methods of analyses, although affected sib-pair (ASP) method revealed an increase in allele sharing among ill individuals, P = 0.023. Since this receptor is within a potential linkage region, ACTHR/MC-2 could be considered a candidate gene for BP.lld:pubmed
pubmed-article:7485268pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7485268pubmed:languageenglld:pubmed
pubmed-article:7485268pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7485268pubmed:citationSubsetIMlld:pubmed
pubmed-article:7485268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7485268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7485268pubmed:statusMEDLINElld:pubmed
pubmed-article:7485268pubmed:monthAuglld:pubmed
pubmed-article:7485268pubmed:issn0148-7299lld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:BerrettiniW...lld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:TurnerGGlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:YoshikawaTTlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:GershonE SESlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:GoldinL RLRlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:YoonS WSWlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:NurnbergerJ...lld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:Detera-Wadlei...lld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:RollinsD YDYlld:pubmed
pubmed-article:7485268pubmed:authorpubmed-author:MuniecDDlld:pubmed
pubmed-article:7485268pubmed:issnTypePrintlld:pubmed
pubmed-article:7485268pubmed:day14lld:pubmed
pubmed-article:7485268pubmed:volume60lld:pubmed
pubmed-article:7485268pubmed:ownerNLMlld:pubmed
pubmed-article:7485268pubmed:authorsCompleteYlld:pubmed
pubmed-article:7485268pubmed:pagination317-21lld:pubmed
pubmed-article:7485268pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:meshHeadingpubmed-meshheading:7485268-...lld:pubmed
pubmed-article:7485268pubmed:year1995lld:pubmed
pubmed-article:7485268pubmed:articleTitleAdrenocorticotropin receptor/melanocortin receptor-2 maps within a reported susceptibility region for bipolar illness on chromosome 18.lld:pubmed
pubmed-article:7485268pubmed:affiliationClinical Neurogenetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.lld:pubmed
pubmed-article:7485268pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7485268pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7485268lld:pubmed